Abiopharma

🔍 Halverson Kenneth (Executive)

Company: RICHARDSON ELECTRONICS, LTD. (RELL)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock at $9.1 per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 19,345.00 | transaction_form_type: 4
• Acquired 5,000 shares of Common Stock at $7.66 per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 24,345.00 | transaction_form_type: 4
• Sold 10,000 shares of Common Stock at $14.6942 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 14,345.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 5,000 shares of Employee Stock Option (Right to Buy) at $9.1 per share (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2028-08-20 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2
• Sold 5,000 shares of Employee Stock Option (Right to Buy) at $7.66 per share (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2031-07-19 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.62 to $14.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Options vest immediately upon grant 8/20/2018
• F3: Options vest immediately upon grant 7/19/2021